Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | HPRT1 | P00492 | 3/20 | 0.49 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | KRAS | P01116 | 8/20 | 0.46 |
| ▸ | HINT1 | P49773 | 1/20 | 0.46 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.45 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.45 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.44 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18158915 | 0.93 | NT5E (0.53) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL20833471 | 0.88 | HPGD (0.51) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL22352197 | 0.86 | NT5E (0.58) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL23679806 | 0.85 | NT5E (0.55) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL18158913 | 0.85 | F2 (0.50) | NT5EFUT5POLBTGM2 | |
| SCHEMBL21454982 | 0.83 | NT5E (0.57) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL18158888 | 0.83 | P2RY1 (0.52) | NT5ETAS1R3TAS1R1 | |
| SCHEMBL12714609 | 0.82 | NT5E (0.70) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL12714572 | 0.81 | FUT5 (0.61) | NT5EFUT5POLBHPRT1TGM2 | |
| SCHEMBL12714596 | 0.81 | FUT5 (0.66) | NT5EFUT5POLBHPRT1TGM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016168592-A2 | COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION | IONIS PHARMACEUTICALS, INC. (US) | 2016-10-20 | — | — | WO | disclosed |